Rock Springs Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$41.4M	Hold	496,871	–	–	2.44%	11
2025 Q4	$38.7M	Buy	496,871 +46,497	+10%	+$3.14M	1.98%	15
2025 Q3	$25.5M	Hold	450,374	–	–	1.49%	24
2025 Q2	$19.7M	Sell	450,374 -344,063	-43%	-$11.8M	1.22%	30
2025 Q1	$21.7M	Sell	794,437 -239,700	-23%	-$8.74M	1.24%	29
2024 Q4	$41.6M	Sell	1,034,137 -15,249	-1%	-$689K	1.58%	20
2024 Q3	$49.7M	Sell	1,049,386 -114,587	-10%	-$5.06M	1.62%	22
2024 Q2	$34.7M	Sell	1,163,973 -358,265	-24%	-$12.4M	1.05%	38
2024 Q1	$61.2M	Hold	1,522,238	–	–	1.56%	21
2023 Q4	$38.8M	Buy	1,522,238 +17,887	+1%	+$320K	0.96%	36
2023 Q3	$20.9M	Buy	1,504,351 +16,800	+1%	+$338K	0.56%	56
2023 Q2	$34.2M	Buy	1,487,551 +259,172	+21%	+$7.43M	0.81%	40
2023 Q1	$36.4M	Buy	1,228,379 +600	+0%	+$19.4K	0.87%	44
2022 Q4	$30.6M	Buy	1,227,779 +181,036	+17%	+$4.83M	0.74%	46
2022 Q3	$22.8M	Buy	1,046,743 +270,864	+35%	+$7.14M	0.59%	50
2022 Q2	$15.3M	Buy	775,879 +20,004	+3%	+$467K	0.44%	61
2022 Q1	$32M	Buy	755,875 +13,810	+2%	+$583K	0.81%	42
2021 Q4	$47.1M	Buy	742,065 +9,138	+1%	+$532K	1.09%	31
2021 Q3	$43.1M	Buy	732,927 +106,400	+17%	+$6.17M	0.91%	38
2021 Q2	$30.4M	Buy	626,527 +4,750	+0.8%	+$206K	0.6%	54
2021 Q1	$24.2M	Sell	621,777 -92,088	-13%	-$5.54M	0.53%	66
2020 Q4	$44.3M	Buy	713,865 +3,900	+0.5%	+$190K	0.94%	34
2020 Q3	$22.9M	Buy	+709,965	New	+$21.7M	0.58%	58